List onesymptom ofUC_________UC is a chronicinflammatorydisease thataffectsthe________Patients with_________should haveregular eyeexamsThemechanismof action ofVelsipity is___________Velsipity hassimilarprogramofferings to____________Velsipity isadministeredvia___________Patients shouldnot_______theirdose of Velsipityto make up for aforgotten doseTherecommendeddoseofVelsipity is______Velsipityshould bestored at___________Anothercommon sideeffect of Velsipityis_____________Each blisterpack ofVelsipitycontains_____or_____tablets____________isa very commonadverse reactionThe Velsipitywelcome call isperformedby__________Velsipity isindicated fortreating___________If more than___consecutivedoses are missednotify HCP fortreatment re-initiationFCM mustescalate to______forapproval if apatient does notmeet criteriaLong-termbridging may beapproved for_______monthsSome patientsrequire a__________thefirst time theytake VelsipityPatientswith__________should haveregular eyeexamsState one pre-treatmentserviceavailable topatients_______________willadvise the CWif the patientmeets bridgingcriteriaThe genericname ofVelsipity is___________Each bottle ofVelsipity willcontain______tabletsOnecommonside effect ofVelsipity is_________List onesymptom ofUC_________UC is a chronicinflammatorydisease thataffectsthe________Patients with_________should haveregular eyeexamsThemechanismof action ofVelsipity is___________Velsipity hassimilarprogramofferings to____________Velsipity isadministeredvia___________Patients shouldnot_______theirdose of Velsipityto make up for aforgotten doseTherecommendeddoseofVelsipity is______Velsipityshould bestored at___________Anothercommon sideeffect of Velsipityis_____________Each blisterpack ofVelsipitycontains_____or_____tablets____________isa very commonadverse reactionThe Velsipitywelcome call isperformedby__________Velsipity isindicated fortreating___________If more than___consecutivedoses are missednotify HCP fortreatment re-initiationFCM mustescalate to______forapproval if apatient does notmeet criteriaLong-termbridging may beapproved for_______monthsSome patientsrequire a__________thefirst time theytake VelsipityPatientswith__________should haveregular eyeexamsState one pre-treatmentserviceavailable topatients_______________willadvise the CWif the patientmeets bridgingcriteriaThe genericname ofVelsipity is___________Each bottle ofVelsipity willcontain______tabletsOnecommonside effect ofVelsipity is_________

Velsipity BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. List one symptom of UC_________
  2. UC is a chronic inflammatory disease that affects the________
  3. Patients with _________ should have regular eye exams
  4. The mechanism of action of Velsipity is ___________
  5. Velsipity has similar program offerings to ____________
  6. Velsipity is administered via ___________
  7. Patients should not _______their dose of Velsipity to make up for a forgotten dose
  8. The recommended doseof Velsipity is ______
  9. Velsipity should be stored at ___________
  10. Another common side effect of Velsipity is _____________
  11. Each blister pack of Velsipity contains _____or _____tablets
  12. ____________is a very common adverse reaction
  13. The Velsipity welcome call is performed by__________
  14. Velsipity is indicated for treating ___________
  15. If more than ___consecutive doses are missed notify HCP for treatment re-initiation
  16. FCM must escalate to ______for approval if a patient does not meet criteria
  17. Long-term bridging may be approved for _______months
  18. Some patients require a __________the first time they take Velsipity
  19. Patients with__________ should have regular eye exams
  20. State one pre-treatment service available to patients______
  21. _________will advise the CW if the patient meets bridging criteria
  22. The generic name of Velsipity is ___________
  23. Each bottle of Velsipity will contain ______tablets
  24. One common side effect of Velsipity is _________